Immunovant, Inc. - Common Stock (NQ:IMVT)All News about Immunovant, Inc. - Common Stock![]()
Immunovant Could Potentially Be An M&A Target, Writes Analyst
February 15, 2023
Via Benzinga
![]()
Benzinga's Top Ratings Upgrades, Downgrades For February 15, 2023
February 15, 2023
Via Benzinga
![]()
Benzinga's Top Ratings Upgrades, Downgrades For February 13, 2023
February 13, 2023
Via Benzinga
![]()
Analyst Expectations for Immunovant's Future
February 07, 2023
Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() Via Benzinga
![]()
Why Senti Biosciences Shares Jumped Over 50%; Here Are 79 Biggest Movers From Yesterday
September 30, 2022
Via Benzinga
![]()
Immunovant's New Candidate Provides Some Strategic Flexibility & Clarity, Analysts Say
September 29, 2022
Via Benzinga
![]() ![]() ![]() ![]() ![]()
Benzinga's Top Ratings Upgrades, Downgrades For September 26, 2022
September 26, 2022
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms Of Service. |
|